Anticoagulant Reversal Drugs Market Worth to Outgrow by USD 1751.5 million By 2027
Posted On September 16, 2021
According to the research report by Value Market Research, the Global Anticoagulant Reversal Drugs Market is likely to grow to USD 1751.5 million by 2027 with a CAGR of 14% during the year 2021-2027. The market's key drivers include the global prevalence of various cardiovascular diseases, atrial fibrillation, increased intracranial and gastrointestinal haemorrhages, and the expanding geriatric population. Manufacturers in the global anticoagulant reversal drugs market are increasing their R&D investments to close the underlying supply and demand gaps in these therapeutics thereby, supplementing the market growth. In addition, approval and introduction of new anticoagulant reversal medicines are likely to boost the market's growth. Because of the link between Covid-19 infection and blood disorders, the impact of Covid-19 on the market for anticoagulant reversal drugs is anticipated to be positive. Nevertheless, the risks associated with anticoagulant reversal and challenges in developing anticoagulant reversal drugs, like stringent clinical trial regulations, are expected to suppress global market growth.
Anticoagulants inhibit blood clotting in people with bleeding disorders like Hemophilia A, Hemophilia B, or Von Willebrand disease. Anticoagulant reversal medicines are needed when anticoagulant therapy must be stopped or reversed due to bleeding issues, an overdose of anticoagulant therapy, or unanticipated surgery. Some of the most regularly used oral anticoagulants are vitamin K antagonists like phenprocoumon and warfarin. Rivaroxaban and dabigatran are non-vitamin K antagonist oral anticoagulants (NOACs). Coronary artery disease, atrial fibrillation, ischemic stroke, deep vein thrombosis, and pulmonary embolism are only a few conditions that necessitate anticoagulant therapy.
"Global Anticoagulant Reversal Drugs Market Report By Product Type (Prothrombin Complex Concentrates, Phytonadione, Andexanet Alfa, Idarucizumab, Protamine, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2021-2027" is an elaborate report providing market data on the basis of segments and geography.
On the basis of product type the market is segmented into Prothrombin Complex Concentrates, Phytonadione, Andexanet Alfa, Idarucizumab, Protamine, Others. By distribution channel the anticoagulant reversal drugs market is categorised as Hospital Pharmacy, Retail Pharmacy, Online Pharmacy. By geography the report is bifurcated into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Anticoagulant Reversal Drugs is the dominating region. The data tables in this section depict the market estimate by market segment.
The Report Segments Global Anticoagulant Reversal Drugs Market -
By Product Type
- Prothrombin Complex Concentrates
- Andexanet Alfa
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
Players Profiled In the Report:
Portola Pharmaceuticals, CSL Behring, Boehringer Ingelheim, Octapharma AG, AMAG Pharmaceuticals, Inc., Dr. Reddy's Laboratories, Pfizer, Inc., Fresenius Kabi AG, Bausch Health Companies Inc., Octapharma AG, SGPharma Pvt. Ltd., and Alps Pharmaceutical Ind. Co., Ltd.
Download the FREE SAMPLE of Global Anticoagulant Reversal Drugs Market Research Report
About Value Market Research -
Value Market Research was established with the vision to ease decision making and empower the strategists by providing them with holistic market information. Our analysts’ team is well equipped with all research tools and techniques and hold deep knowledge of the industry they are working for.
We ensure intellectual, precise and quality data is delivered to our client. We facilitate clients with syndicate research reports and customized research reports on 25+ industries with global as well as regional coverage.
Value Market Research
401/402, TFM, Nagras Road, Aundh, Pune-7.
Email: [email protected]